Bioequivalence and Bioavailability Forum

Subject	Author	Posted	Rep.	last R.	Views
BE parallel design BE parallel design BE parallel design BE parallel design a posteriori power... a posteriori power... a posteriori power... a posteriori power...	Sathya	2008-09-06 06:46	7	2008-09-10 07:49	9,963
Pharmacokinetic calculation in missing samples	drplacebo	2008-11-10 09:05	0		4,704
failed bioequivalence study failed bioequivalence study	A-M-R	2009-05-24 13:47	1	2009-05-24 12:48	4,961
Missing samples in terminal elimination phase Missing samples in terminal elimination phase Missing samples in terminal elimination phase Missing samples in terminal elimination phase Missing samples in terminal elimination phase	Bhupesh	2009-10-12 14:14	4	2009-10-13 16:24	8,791
drug concentration nil in both periods drug concentration <LLOQ in both periods drug concentration <LLOQ in both periods drug concentration <LLOQ in both periods drug concentration <LLOQ in both periods drug concentration <LLOQ in both periods	VP	2009-10-14 09:10	5	2009-10-15 12:13	6,111
Inadequate Concentrations Inadequate Concentrations Inadequate Concentrations Inadequate Concentrations	kiranActimus	2010-02-18 09:00	3	2010-03-12 08:10	5,498
Pre-dose concentrations in period 2 Pre-dose concentrations in period 2 Pre-dose concentrations in period 2	Averroes	2011-02-22 14:05	2	2011-02-22 17:14	5,400
Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study…	H.Patel	2011-06-15 16:28	11	2011-06-18 09:53	12,419
Pre Treatment drug levels Pre Treatment drug levels Pre Treatment drug levels Protocol Deviation	JOI	2011-11-16 11:57	3	2011-11-16 17:11	6,805
pre-dose concentrations above LLOQ pre-dose concentrations above LLOQ pre-dose concentrations above LLOQ pre-dose concentrations above LLOQ pre-dose concentrations above LLOQ pre-dose concentrations above LLOQ	Paola	2011-12-21 12:58	5	2011-12-22 21:06	8,432
Predose concentration more than 5 % of Cmax Exclusion of subjects (predose >5 % of Cmax)	kamblpa1	2011-12-27 05:19	1	2011-12-27 17:35	7,791
Statistical Out come Statistical Out come Statistical Out come	auditor	2012-02-01 12:58	2	2012-02-02 18:13	5,068
To calculate AUC0-inf in Scaled average bioequivalence Completely lost sequence in partial replicate	aquapurple	2012-08-24 11:50	1	2012-08-24 18:07	5,305
First point Cmax First point Cmax First point Cmax First point Cmax First point Cmax	auditor	2012-02-10 06:50	4	2012-09-10 11:54	9,655
high concentration in the elimination phase-Metaxalone high concentration in the elimination phase-Metaxalone high concentration in the elimination phase-Metaxalone Enterohepatic recirculation Enterohepatic recirculation Enterohepatic recirculation high concentration in the elimination phase-Metaxalone high concentration in the elimination phase-Metaxalone high concentration in the elimination phase-Metaxalone	cakhatri	2012-09-07 05:58	8	2012-09-14 04:30	10,918